SAISEIKEN CO., LTD. succeed an exploratory clinical study to evaluate the Stem Cell from Human exfoliated Deciduous teeth derived Conditioned Medium (SHED-CM) for the treatment of amyotrophic lateral sclerosis (ALS)

下载PDF

ALS_En2022-1-18